Astragalus polysaccharide suppresses excessive collagen accumulation in a murine model of bleomycin-induced scleroderma

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 3, 2015, Pages 3848-3854

  Hao, Zhen Feng ^a   Su, You Ming ^a   Liu, Jing Yang ^a   Wang, Cong Min ^a   Yang, Rong Ya ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

APS; Bleomycin induced fibrosis; Transforming growth factor 1

Indexed keywords

BLEOMYCIN; GAMMA INTERFERON; HYDROXYPROLINE; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYSACCHARIDE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTRAGALUS (PLANT); BLEOMYCIN INDUCED SCLERODERMA; COLLAGEN METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INDUCED DISEASE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCLERODERMA; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ASTRAGALUS MONGHOLICUS; MURINAE; MUS;

EID: 84929353388     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Akamata K, Asano Y, Aozasa N, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Toyama T and Sato S. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1. Arthritis Res Ther 2014; 16: R86.
2. Levis B, Burri A, Hudson M, Baron M and Thombs BD. Sexual activity and impairment in women with systemic sclerosis compared to women from a general population sample. PLoS One 2012; 7: e52129.
3. Bandinelli F, Del RA, Gabrielli A, Giacomelli R, Bartoli F, Guiducci S and Matucci CM. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: The correlation with SSc clinical features and the effect of prostaglandin E1 treatment. Clin Exp Rheumatol 2012; 30: S44-S49.
4. Hasegawa M and Takehara K. Potential immunologic targets for treating fibrosis in systemic sclerosis: A review focused on leukocytes and cytokines. Semin Arthritis Rheum 2012; 42: 281-296.
5. Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P and Giacomelli R. Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 2011; 10: 590-594.
6. Li M, Wang W, Xue J, Gu Y and Lin S. Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. J Ethnopharmacol 2011; 133: 412-419.
7. Wojcikowski K, Wohlmuth H, Johnson DW and Gobe G. Effect of Astragalus membranaceus and Angelica sinensis combined with Enalapril in rats with obstructive uropathy. Phytother Res 2010; 24: 875-884.
8. Gao XH, Xu XX, Pan R, Li Y, Luo YB, Xia YF, Murata K, Matsuda H and Dai Y. Saponin fraction from Astragalus membranaceus roots protects mice against polymicrobial sepsis induced by cecal ligation and puncture by inhibiting inflammation and upregulating protein C pathway. J Nat Med 2009; 63: 421-429.
9. Yang B, Xiao B and Sun T. Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice. Int J Biol Macromol 2013; 62: 287-290.
10. Li XT, Zhang YK, Kuang HX, Jin FX, Liu DW, Gao MB, Liu Z and Xin XJ. Mitochondrial protection and anti-aging activity of astragalus polysaccharides and their potential mechanism. Int J Mol Sci 2012; 13: 1747-1761.
11. Yang B, Xiao B and Sun T. Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice. Int J Biol Macromol 2013; 62: 287-290.
12. Zhou XM, Zhang GC, Li JX and Hou J. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats. J Ethnopharmacol 2007; 111: 255-264.
13. Zhu H, Luo H, Li Y, Zhou Y, Jiang Y, Chai J, Xiao X, You Y and Zuo X. MicroRNA-21 in scleroderma fibrosis and its function in TGF-beta-regulated fibrosis-related genes expression. J Clin Immunol 2013; 33: 1100-1109.
14. Leask A. Signaling in fibrosis: Targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma. Front Biosci (Elite Ed) 2009; 1: 115-122.
15. Lakos G, Takagawa S, Chen SJ, Ferreira AM, Han G, Masuda K, Wang XJ, DiPietro LA and Varga J. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol 2004; 165: 203-217.
16. Honda N, Jinnin M, Kajihara I, Makino T, Makino K, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M and Ihn H. TGF-beta-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. J Immunol 2012; 188: 3323-3331.
17. Shi S, Yu L, Zhang T, Qi H, Xavier S, Ju W and Bottinger E. Smad2-dependent downregulation of miR-30 is required for TGF-beta-induced apoptosis in podocytes. PLoS One 2013; 8: e75572.
18. Sengupta S, Kundu S and Bhattacharyya A. Attenuation of Smad2 activity shows resistance to TGF-beta signalling in mammary adenocarcinoma (MCF-7) cells. Cell Biol Int 2013; 37: 449-457.
19. Yang T, Zhang B, Pat BK, Wei MQ and Gobe GC. Lentiviral-mediated RNA interference against TGF-beta receptor type II in renal epithelial and fibroblast cell populations in vitro demonstrates regulated renal fibrogenesis that is more efficient than a nonlentiviral vector. J Biomed Biotechnol 2010; 2010: 859240.
20. Lee EK, Lee YS, Han IO and Park SH. Expression of Caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells. Biochem Biophys Res Commun 2007; 359: 385-390.
21. Zhang Q, Fong CC, Yu WK, Chen Y, Wei F, Koon CM, Lau KM, Leung PC, Lau CB, Fung KP and Yang M. Herbal formula Astragali Radix and Rehmanniae Radix exerted wound healing effect on human skin fibroblast cell line Hs27 via the activation of transformation growth factor (TGF-beta) pathway and promoting extracellular matrix (ECM) deposition. Phytomedicine 2012; 20: 9-16.